CJC-1295 is a Growth Hormone–Releasing Hormone (GHRH) analog formulated to stimulate the pituitary gland and promote a sustained, natural increase in growth hormone (GH) and IGF-1 levels. By enhancing the body’s own GH production, CJC-1295 supports muscle growth, fat metabolism, recovery, and cellular repair, offering a safe and effective option for patients seeking long-term hormone optimization and performance enhancement.
Our lyophilized peptides deliver 99%+ purity and are manufactured in the USA with APIs listed on the FDA Green List. We partner exclusively with cGMP and ISO 9001 registered facilities to ensure that every ingredient meets stringent purity and efficacy benchmarks, guaranteeing consistency and efficacy across all production runs. Certificate of Analysis available upon request.
Key Benefits for Your Patients:
- Increased Lean Muscle Mass: Stimulates GH and IGF-1 production to promote muscle development, repair, and strength gains.
- Enhanced Fat Metabolism: Supports lipolysis and improved body composition through natural fat-burning mechanisms.
- Faster Recovery and Cellular Repair: Accelerates healing and recovery after exercise, injury, or aesthetic procedures.
- Improved Energy and Vitality: Boosts mitochondrial function and overall metabolic efficiency for enhanced daily performance.
- Safe for Long-Term Use: Maintains pituitary sensitivity and hormonal balance, supporting sustainable results.
CJC-1295 delivers a natural, physiologic approach to growth hormone enhancement, offering providers a well-tolerated, evidence-based peptide that supports muscle development, fat reduction, and tissue repair. Its ability to promote sustained GH release without hormonal suppression makes it a cornerstone therapy in regenerative, wellness, and performance medicine.
Each vial is provided in lyophilized powder form and must be reconstituted with bacteriostatic water prior to use.
This product is intended for use under the guidance of qualified medical professionals who prioritize precision, quality, and evidence-based peptide therapies in patient care.
